<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Clin North Am</journal-id><journal-id journal-id-type="iso-abbrev">Med Clin North Am</journal-id><journal-title-group><journal-title>The Medical Clinics of North America</journal-title></journal-title-group><issn pub-type="ppub">0025-7125</issn><issn pub-type="epub">1557-9859</issn><publisher><publisher-name>Elsevier Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">3280914</article-id><article-id pub-id-type="pmc">7131553</article-id><article-id pub-id-type="pii">S0025-7125(16)30766-0</article-id><article-id pub-id-type="doi">10.1016/S0025-7125(16)30766-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antiviral Agents</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Reines</surname><given-names>Eric D.</given-names></name><degrees>MD</degrees><xref rid="aff0005" ref-type="aff">*</xref><xref rid="cor0005" ref-type="corresp">**</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Gross</surname><given-names>Peter A.</given-names></name><degrees>MD</degrees><xref rid="aff0010" ref-type="aff">&#x02020;</xref></contrib><aff id="aff0005"><label>*</label>Fellow, Division of Infectious Diseases, Hackensack Medical Center, Hackensack, New Jersey</aff><aff id="aff0010"><label>&#x02020;</label>Professor of Medicine, New Jersey Medical School, University of Medicine and Dentistry, Newark; and Director of Internal Medicine, Division of Infectious Diseases, Hackensack Medical Center, Hackensack, New Jersey</aff></contrib-group><author-notes><corresp id="cor0005"><label>**</label>Department of Internal Medicine, Hackensack Medical Center, 30 Prospect Avenue, Hackensack, NJ 07601</corresp></author-notes><pub-date pub-type="pmc-release"><day>6</day><month>4</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>5</month><year>1988</year></pub-date><pub-date pub-type="epub"><day>6</day><month>4</month><year>2016</year></pub-date><volume>72</volume><issue>3</issue><fpage>691</fpage><lpage>715</lpage><permissions><copyright-statement>Copyright &#x000a9; 1988 Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>1988</copyright-year><copyright-holder>Elsevier Inc.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1.</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>J.</given-names></name><name><surname>Britton</surname><given-names>S.</given-names></name><name><surname>Ernberg</surname><given-names>I.</given-names></name></person-group><article-title>Effect of acyclovir on infectious mononucleosis: A double-blind, placebo-controlled study</article-title><source>J Infect Dis</source><volume>2</volume><year>1986</year><fpage>282</fpage></element-citation></ref><ref id="bib0010"><label>2.</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Aronoff</surname><given-names>C.R.</given-names></name><name><surname>Szwel</surname><given-names>J.J.</given-names></name><name><surname>Nelson</surname><given-names>R.L.</given-names></name></person-group><article-title>Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration</article-title><source>Antimicrob Agents Chemother</source><volume>15</volume><year>1979</year><fpage>142</fpage><pub-id pub-id-type="pmid">426502</pub-id></element-citation></ref><ref id="bib0015"><label>3.</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Bacl</surname><given-names>M.C.</given-names></name><name><surname>Bagwell</surname><given-names>S.P.</given-names></name><name><surname>Knapp</surname><given-names>N.P.</given-names></name></person-group><article-title>9-(1,3 dihydroxy-2-propoxymethyl) guanine for cytomegalovirus. Infections in patients with the acquired immunodeficiency syndrome</article-title><source>Ann Intern Med</source><volume>103</volume><year>1985</year><fpage>381</fpage><pub-id pub-id-type="pmid">2992335</pub-id></element-citation></ref><ref id="bib0020"><label>4.</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Balfour</surname><given-names>H.H.</given-names></name><name><surname>Bean</surname><given-names>B.</given-names></name><name><surname>Laskin</surname><given-names>O.L.</given-names></name></person-group><article-title>Acyclovir halts progression of herpes zoster in immunocompromised patients</article-title><source>N Engl J Med</source><volume>308</volume><year>1983</year><fpage>1448</fpage><pub-id pub-id-type="pmid">6343861</pub-id></element-citation></ref><ref id="bib0025"><label>5.</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Balzarini</surname><given-names>J.</given-names></name><name><surname>Mitsuya</surname><given-names>H.</given-names></name><name><surname>De Clerc</surname><given-names>E.</given-names></name></person-group><article-title>Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of HTLV-III/LAV</article-title><source>Int J Cancer</source><volume>37</volume><year>1986</year><fpage>451</fpage><pub-id pub-id-type="pmid">2419266</pub-id></element-citation></ref><ref id="bib0030"><label>6.</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Bassendine</surname><given-names>M.F.</given-names></name><name><surname>Chadwick</surname><given-names>R.G.</given-names></name><name><surname>Salmeron</surname><given-names>J.</given-names></name></person-group><article-title>Adenosine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study</article-title><source>Gastroenterology</source><volume>80</volume><year>1981</year><fpage>1016</fpage><pub-id pub-id-type="pmid">7009310</pub-id></element-citation></ref><ref id="bib0035"><label>7.</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>B.</given-names></name><name><surname>Aeppli</surname><given-names>D.</given-names></name></person-group><article-title>Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster</article-title><source>J Infect Dis</source><volume>2</volume><year>1985</year><fpage>362</fpage></element-citation></ref><ref id="bib0040"><label>8.</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>B.</given-names></name><name><surname>Braun</surname><given-names>C.</given-names></name><name><surname>Balfour</surname><given-names>H.H.</given-names></name></person-group><article-title>Acyclovir therapy for acute herpes zoster</article-title><source>Lancet</source><volume>2</volume><year>1982</year><fpage>118</fpage><pub-id pub-id-type="pmid">6123837</pub-id></element-citation></ref><ref id="bib0045"><label>9.</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Bektimirov</surname><given-names>T.A.</given-names></name><name><surname>Douglas</surname><given-names>R.A.</given-names></name><name><surname>Dolin</surname><given-names>R.</given-names></name></person-group><article-title>Current status of amantadine and rimantadine as anti-influenza agents</article-title><source>Bull Who</source><volume>63</volume><year>1985</year><fpage>51</fpage><pub-id pub-id-type="pmid">3872736</pub-id></element-citation></ref><ref id="bib0050"><label>10.</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>K.K.</given-names></name><name><surname>Fyfe</surname><given-names>J.A.</given-names></name><name><surname>Noblin</surname><given-names>J.E.</given-names></name></person-group><article-title>Selection and primary characterization of acyclovir-resistant mutants of varicella-zoster virus</article-title><source>Am J Med</source><volume>73</volume><issue>Suppl</issue><year>1982</year><fpage>383</fpage><pub-id pub-id-type="pmid">6285728</pub-id></element-citation></ref><ref id="bib0055"><label>11.</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Broder</surname><given-names>S.</given-names></name><name><surname>Collins</surname><given-names>J.M.</given-names></name><name><surname>Markham</surname><given-names>P.D.</given-names></name></person-group><article-title>Effects of suramin on HTLV-III/LAV infection presenting as Kaposi&#x02019;s sarcoma or AIDS-related complex: Clinical pharmacology and suppression of virus replication in vivo</article-title><source>Lancet</source><volume>2</volume><year>1985</year><fpage>627</fpage><pub-id pub-id-type="pmid">2863631</pub-id></element-citation></ref><ref id="bib0060"><label>12.</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Ceffen</surname><given-names>J.R.</given-names></name><name><surname>Klein</surname><given-names>R.J.</given-names></name><name><surname>Friedman-Kris</surname><given-names>A.E.</given-names></name></person-group><article-title>Intralesional administration of large dose of human leukocyte interferon for the treatment of condyloma</article-title><source>J Infect Dis</source><volume>150</volume><year>1984</year><fpage>612</fpage><pub-id pub-id-type="pmid">6491370</pub-id></element-citation></ref><ref id="bib0065"><label>13.</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Champrey</surname><given-names>K.J.</given-names></name><name><surname>Lacter</surname><given-names>C.B.</given-names></name><name><surname>Bailey</surname><given-names>E.J.</given-names></name></person-group><article-title>Antiherpes activity in human sera and urine after administration of adenosine arabinoside</article-title><source>J Clin Invest</source><volume>62</volume><year>1978</year><fpage>1142</fpage><pub-id pub-id-type="pmid">219024</pub-id></element-citation></ref><ref id="bib0070"><label>14.</label><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>N.L.</given-names></name><name><surname>Balfour</surname><given-names>H.H.</given-names></name></person-group><article-title>Varicella-zoster does not become more resistant to acyclovir during therapy</article-title><source>J Infect Dis</source><volume>3</volume><year>1986</year><fpage>605</fpage></element-citation></ref><ref id="bib0075"><label>15.</label><element-citation publication-type="journal" id="sbref0075"><article-title>Collaborative DHPG treatment study group: Treatment of serious cytomegalovirus infections with 9-(l,3 dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies</article-title><source>N Engl J Med</source><volume>314</volume><year>1986</year><fpage>801</fpage><pub-id pub-id-type="pmid">3005861</pub-id></element-citation></ref><ref id="bib0080"><label>16.</label><element-citation publication-type="book" id="sbref0080"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>J.D.</given-names></name><name><surname>Hintz</surname><given-names>M.</given-names></name><name><surname>Van Dyke</surname><given-names>R.</given-names></name></person-group><chapter-title>Ribavirin pharmacokinetics in children and adults during therapeutic trials</chapter-title><person-group person-group-type="editor"><name><surname>Smith</surname><given-names>R.A.</given-names></name><name><surname>Knight</surname><given-names>V.</given-names></name><name><surname>Smith</surname><given-names>J.A.D.</given-names></name></person-group><source>Clinical Applications of Ribavirin</source><year>1984</year><publisher-name>Academic Press</publisher-name><publisher-loc>New York</publisher-loc><fpage>107</fpage></element-citation></ref><ref id="bib0085"><label>17.</label><element-citation publication-type="book" id="sbref0085"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>J.D.</given-names></name><name><surname>Van Dyke</surname><given-names>R.</given-names></name><name><surname>Hintz</surname><given-names>M.</given-names></name></person-group><chapter-title>Pharmacokinetics of ribavirin small-particle aerosol therapy in children and adults</chapter-title><source>23rd ICAAC, abstract no. 932</source><year>1983</year><fpage>256</fpage></element-citation></ref><ref id="bib0090"><label>18.</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Corey</surname><given-names>L.</given-names></name><name><surname>Fife</surname><given-names>K.H.</given-names></name><name><surname>Beneditti</surname><given-names>J.K.</given-names></name></person-group><article-title>Intravenous acyclovir for the treatment of primary genital herpes</article-title><source>Ann Intern Med</source><volume>98</volume><year>1983</year><fpage>914</fpage><pub-id pub-id-type="pmid">6305244</pub-id></element-citation></ref><ref id="bib0095"><label>19.</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Couch</surname><given-names>R.B.</given-names></name><name><surname>Kasel</surname><given-names>J.A.</given-names></name><name><surname>Glezen</surname><given-names>W.P.</given-names></name></person-group><article-title>Influenza: Its control in persons and populations</article-title><source>J Infect Dis</source><volume>153</volume><year>1986</year><fpage>431</fpage><pub-id pub-id-type="pmid">3950437</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Crumpacker</surname><given-names>C.</given-names></name><name><surname>Heagy</surname><given-names>W.</given-names></name><name><surname>Bubley</surname><given-names>G.</given-names></name></person-group><article-title>Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome- related complex (ARC)</article-title><source>Ann Intern Med</source><volume>107</volume><year>1987</year><fpage>664</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">3662279</pub-id></element-citation></ref><ref id="bib0105"><label>20.</label><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Culbert</surname><given-names>B.E.</given-names></name><name><surname>Knight</surname><given-names>V.</given-names></name></person-group><article-title>Minireview: Biochemistry and clinical applications of ribavirin</article-title><source>Antimicrob Agents Chemother</source><volume>30</volume><year>1986</year><fpage>201</fpage><pub-id pub-id-type="pmid">2876677</pub-id></element-citation></ref><ref id="bib0110"><label>21.</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>J.M.</given-names></name><name><surname>Rogers</surname><given-names>M.</given-names></name><name><surname>Judson</surname><given-names>F.N.</given-names></name></person-group><article-title>The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alphainterferon</article-title><source>J Infect Dis</source><volume>2</volume><year>1986</year><fpage>331</fpage></element-citation></ref><ref id="bib0115"><label>22.</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>R.M.</given-names></name><name><surname>Moore</surname><given-names>B.W.</given-names></name><name><surname>Miles</surname><given-names>H.B.</given-names></name></person-group><article-title>Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting</article-title><source>N Engl J Med</source><volume>314</volume><year>1986</year><fpage>65</fpage><pub-id pub-id-type="pmid">3001518</pub-id></element-citation></ref><ref id="bib0120"><label>23.</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Elion</surname><given-names>G.B.</given-names></name></person-group><article-title>Mechanism of action and selectivity of acyclovir</article-title><source>Am J Med</source><volume>73</volume><issue>Suppl</issue><year>1982</year><fpage>7</fpage><pub-id pub-id-type="pmid">6285736</pub-id></element-citation></ref><ref id="bib0125"><label>24.</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Fauci</surname><given-names>A.S.</given-names></name><name><surname>Rosenberg</surname><given-names>S.A.</given-names></name><name><surname>Sherwin</surname><given-names>S.A.</given-names></name></person-group><article-title>Immunomodulators in clinical medicine</article-title><source>Ann Intern Med</source><volume>106</volume><year>1987</year><fpage>421</fpage><pub-id pub-id-type="pmid">2433978</pub-id></element-citation></ref><ref id="bib0130"><label>25.</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Felsenstein</surname><given-names>D.</given-names></name><name><surname>D&#x02019;Amis</surname><given-names>D.J.</given-names></name><name><surname>Hirsch</surname><given-names>M.S.</given-names></name></person-group><article-title>Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-l-(hydroxymethyl) ethoxymethyl] guanine</article-title><source>Ann Intern Med</source><volume>103</volume><year>1985</year><fpage>377</fpage><pub-id pub-id-type="pmid">2992334</pub-id></element-citation></ref><ref id="bib0135"><label>26.</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Field</surname><given-names>H.</given-names></name><name><surname>McMillan</surname><given-names>A.</given-names></name><name><surname>Darby</surname><given-names>G.</given-names></name></person-group><article-title>The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs</article-title><source>J Infect Dis</source><volume>143</volume><year>1981</year><fpage>281</fpage><pub-id pub-id-type="pmid">6260876</pub-id></element-citation></ref><ref id="bib0140"><label>27.</label><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>D.J.</given-names></name><name><surname>Sheth</surname><given-names>N.V.</given-names></name><name><surname>Spruance</surname><given-names>S.L.</given-names></name></person-group><article-title>Failure of topical acyclovir in ointment to penetrate human skin</article-title><source>Antimicrob Agents Chemother</source><volume>5</volume><year>1986</year><fpage>730</fpage></element-citation></ref><ref id="bib0145"><label>28.</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Gephart</surname><given-names>J.F.</given-names></name><name><surname>Lerner</surname><given-names>A.M.</given-names></name></person-group><article-title>Comparison of the effects of arabinosyladenine, arabinosyladenine 5&#x02019;-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis</article-title><source>Antimicrob Agents Chemother</source><volume>19</volume><year>1981</year><fpage>170</fpage><pub-id pub-id-type="pmid">6166244</pub-id></element-citation></ref><ref id="bib0150"><label>29.</label><element-citation publication-type="book" id="sbref0150"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>B.E.</given-names></name><name><surname>Wilson</surname><given-names>S.Z.</given-names></name><name><surname>Knight</surname><given-names>V.</given-names></name></person-group><chapter-title>Ribavirin small-particle aerosol treatment of influenza in college students 1981-83</chapter-title><person-group person-group-type="editor"><name><surname>Smith</surname><given-names>R.A.</given-names></name><name><surname>Knight</surname><given-names>V.</given-names></name><name><surname>Smith</surname><given-names>J.A.D.</given-names></name></person-group><source>Clinical Applications of Ribavirin</source><year>1984</year><publisher-name>Academic Press</publisher-name><publisher-loc>New York</publisher-loc><fpage>125</fpage></element-citation></ref><ref id="bib0155"><label>30.</label><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>D.</given-names></name><name><surname>Corey</surname><given-names>L.</given-names></name></person-group><article-title>Acyclovir prophylaxis for herpes simplex virus infections</article-title><source>Antimicrob Agents Chemother</source><volume>31</volume><year>1987</year><fpage>361</fpage><pub-id pub-id-type="pmid">3555331</pub-id></element-citation></ref><ref id="bib0160"><label>31.</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C.B.</given-names></name></person-group><article-title>Ribavirin: Beginning the blitz on respiratory viruses</article-title><source>Pediatr Infect Dis</source><volume>4</volume><year>1985</year><fpage>668</fpage><pub-id pub-id-type="pmid">3001662</pub-id></element-citation></ref><ref id="bib0165"><label>32.</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C.B.</given-names></name><name><surname>Walsh</surname><given-names>E.E.</given-names></name><name><surname>Hrushka</surname><given-names>J.F.</given-names></name></person-group><article-title>Ribavirin treatment of experimental respiratory syncytial virus infection: A controlled double-blind study</article-title><source>JAMA</source><volume>249</volume><year>1983</year><fpage>2666</fpage><pub-id pub-id-type="pmid">6341640</pub-id></element-citation></ref><ref id="bib0170"><label>33.</label><element-citation publication-type="book" id="sbref0170"><person-group person-group-type="author"><name><surname>Haratshorn</surname><given-names>K.L.</given-names></name><name><surname>Hirsch</surname><given-names>M.S.</given-names></name></person-group><chapter-title>Interferons</chapter-title><person-group person-group-type="editor"><name><surname>Peterson</surname><given-names>P.K.</given-names></name><name><surname>Verhoef</surname><given-names>J.</given-names></name></person-group><source>Antimicrobial Agents Annual</source><year>1986</year><publisher-name>Elsevier Science Publishers</publisher-name><publisher-loc>Amsterdam</publisher-loc><fpage>344</fpage></element-citation></ref><ref id="bib0175"><label>34.</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>F.G.</given-names></name><name><surname>Albrecht</surname><given-names>J.K.</given-names></name><name><surname>Kaiser</surname><given-names>D.L.</given-names></name></person-group><article-title>Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon</article-title><source>N Engl J Med</source><volume>314</volume><year>1986</year><fpage>71</fpage><pub-id pub-id-type="pmid">3001519</pub-id></element-citation></ref><ref id="bib0180"><label>35.</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>G.F.</given-names></name><name><surname>Hendley</surname><given-names>J.O.</given-names></name><name><surname>Gwaltney</surname><given-names>J.M.</given-names></name></person-group><article-title>The effect of placebo and virucidal paper handkerchiefs on viral containment of the hand transmission of experimental rhinoviral infection</article-title><source>J Infect Dis</source><volume>2</volume><year>1985</year><fpage>403</fpage></element-citation></ref><ref id="bib0185"><label>36.</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>M.S.</given-names></name><name><surname>Kaplan</surname><given-names>J.C.</given-names></name></person-group><article-title>Antiviral therapy</article-title><source>Sei Am</source><volume>7</volume><year>1987</year><fpage>76</fpage></element-citation></ref><ref id="bib0190"><label>37.</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>D.D.</given-names></name><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name><name><surname>Rota</surname><given-names>T.R.</given-names></name></person-group><article-title>Recombinant human alpha interferon suppresses HTLV-III replication in vitro</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>602</fpage><pub-id pub-id-type="pmid">2857946</pub-id></element-citation></ref><ref id="bib0195"><label>38.</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Ikossi-Commor</surname><given-names>M.G.</given-names></name><name><surname>Chadhu</surname><given-names>K.</given-names></name></person-group><article-title>Interferon inactivators in patients with AIDS and AIDS-related Kaposi&#x02019;s sarcoma</article-title><source>Am J Med</source><volume>81</volume><year>1986</year><fpage>783</fpage><pub-id pub-id-type="pmid">2430452</pub-id></element-citation></ref><ref id="bib0200"><label>39.</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Johns</surname><given-names>D.R.</given-names></name><name><surname>Gress</surname><given-names>D.R.</given-names></name></person-group><article-title>Rapid response to acyclovir in herpes zoster associated encephalitis</article-title><source>Am J Med</source><volume>82</volume><year>1987</year><fpage>560</fpage><pub-id pub-id-type="pmid">3826110</pub-id></element-citation></ref><ref id="bib0205"><label>40.</label><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>L.D.</given-names></name><name><surname>Wolfe</surname><given-names>P.R.</given-names></name><name><surname>Volberding</surname><given-names>P.A.</given-names></name></person-group><article-title>Lack of response to suramin in patients with AIDS and AIDS-related complex</article-title><source>Am J Med</source><volume>82</volume><year>1987</year><fpage>615</fpage><pub-id pub-id-type="pmid">3548350</pub-id></element-citation></ref><ref id="bib0210"><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Keay</surname><given-names>S.</given-names></name><name><surname>Bissett</surname><given-names>J.</given-names></name><name><surname>Merigan</surname><given-names>T.C.</given-names></name></person-group><article-title>Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients</article-title><source>J Infect Dis</source><volume>156</volume><year>1987</year><fpage>1016</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">2824621</pub-id></element-citation></ref><ref id="bib0215"><label>41.</label><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>P.M.</given-names></name><name><surname>Fyfe</surname><given-names>J.A.</given-names></name></person-group><article-title>Enzymatic phosphorylation of acyclic nucleoside analogs and correlation with antiherpetic activities</article-title><source>Biochem Pharmacol</source><volume>301</volume><year>1981</year><fpage>3071</fpage></element-citation></ref><ref id="bib0220"><label>42.</label><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>R.H.</given-names></name><name><surname>Canorico</surname><given-names>P.G.</given-names></name><name><surname>Green</surname><given-names>D.E.</given-names></name></person-group><article-title>Effect of ribavirin and tributylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs</article-title><source>Antimicrob Agents Chemother</source><volume>29</volume><year>1986</year><fpage>521</fpage><pub-id pub-id-type="pmid">3013087</pub-id></element-citation></ref><ref id="bib0225"><label>43.</label><element-citation publication-type="journal" id="sbref0225"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>V.</given-names></name><name><surname>Wilson</surname><given-names>S.Z.</given-names></name><name><surname>Quartis</surname><given-names>J.M.</given-names></name></person-group><article-title>Ribavirin small-particle aerosol treatment of influenza</article-title><source>Lancet</source><volume>1</volume><year>1981</year><fpage>945</fpage></element-citation></ref><ref id="bib0230"><label>44.</label><element-citation publication-type="journal" id="sbref0230"><person-group person-group-type="author"><name><surname>Krasny</surname><given-names>H.C.</given-names></name><name><surname>Liao</surname><given-names>S.H.T.</given-names></name><name><surname>DeMiranda</surname><given-names>P.</given-names></name></person-group><article-title>Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure</article-title><source>Am J Med</source><volume>73</volume><issue>Suppl</issue><year>1982</year><fpage>202</fpage><pub-id pub-id-type="pmid">7102703</pub-id></element-citation></ref><ref id="bib0235"><label>45.</label><element-citation publication-type="journal" id="sbref0235"><person-group person-group-type="author"><name><surname>Kuhls</surname><given-names>T.L.</given-names></name><name><surname>Sacher</surname><given-names>J.</given-names></name><name><surname>Pineda</surname><given-names>E.</given-names></name></person-group><article-title>Suppression of recurrent genital herpes simplex virus infection with recombinant alpha interferon</article-title><source>J Infect Dis</source><volume>3</volume><year>1986</year><fpage>437</fpage></element-citation></ref><ref id="bib0240"><label>46.</label><element-citation publication-type="journal" id="sbref0240"><person-group person-group-type="author"><name><surname>Lagrew</surname><given-names>D.C.</given-names></name><name><surname>Furlow</surname><given-names>T.G.</given-names></name><name><surname>Hager</surname><given-names>D.</given-names></name></person-group><article-title>Disseminated herpes simplex virus infection in pregnancy</article-title><source>JAMA</source><volume>15</volume><year>1984</year><fpage>2058</fpage></element-citation></ref><ref id="bib0245"><label>47.</label><element-citation publication-type="journal" id="sbref0245"><person-group person-group-type="author"><name><surname>Laskin</surname><given-names>O.</given-names></name></person-group><article-title>Acyclovir and suppression of frequently recurring herpetic whitlow</article-title><source>Ann Intern Med</source><volume>4</volume><year>1985</year><fpage>494</fpage></element-citation></ref><ref id="bib0250"><label>48.</label><element-citation publication-type="journal" id="sbref0250"><person-group person-group-type="author"><name><surname>Lehrman</surname><given-names>S.N.</given-names></name><name><surname>Douglas</surname><given-names>J.M.</given-names></name><name><surname>Corey</surname><given-names>L.</given-names></name></person-group><article-title>Recurrent genital herpes and suppressive oral acyclovir therapy</article-title><source>Ann Intern Med</source><volume>104</volume><year>1986</year><fpage>786</fpage><pub-id pub-id-type="pmid">3010782</pub-id></element-citation></ref><ref id="bib0255"><label>49.</label><element-citation publication-type="journal" id="sbref0255"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>A.M.</given-names></name><name><surname>Gill</surname><given-names>P.S.</given-names></name><name><surname>Cohen</surname><given-names>J.</given-names></name></person-group><article-title>Suramin antiviral therapy in the acquired immuno deficiency syndrome</article-title><source>Ann Intern Med</source><volume>105</volume><year>1986</year><fpage>32</fpage><pub-id pub-id-type="pmid">2424353</pub-id></element-citation></ref><ref id="bib0260"><label>50.</label><element-citation publication-type="journal" id="sbref0260"><person-group person-group-type="author"><name><surname>Lietman</surname><given-names>P.</given-names></name></person-group><article-title>Acyclovir clinical pharmacology: An overview</article-title><source>Am J Med</source><volume>73</volume><issue>Suppl</issue><year>1982</year><fpage>193</fpage><pub-id pub-id-type="pmid">7048912</pub-id></element-citation></ref><ref id="bib0265"><label>51.</label><element-citation publication-type="journal" id="sbref0265"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Vriend</surname><given-names>G.</given-names></name><name><surname>Kamen</surname><given-names>G.</given-names></name></person-group><article-title>The atomic structure of Mengo virus at 3.0: A resolution</article-title><source>Science</source><volume>235</volume><year>1987</year><fpage>182</fpage><pub-id pub-id-type="pmid">3026048</pub-id></element-citation></ref><ref id="bib0270"><label>52.</label><element-citation publication-type="journal" id="sbref0270"><person-group person-group-type="author"><name><surname>Masur</surname><given-names>H.</given-names></name><name><surname>Lane</surname><given-names>C.</given-names></name><name><surname>Palestine</surname><given-names>A.</given-names></name></person-group><article-title>Effect of 9-(l, 3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men</article-title><source>Ann Intern Med</source><volume>104</volume><year>1986</year><fpage>41</fpage><pub-id pub-id-type="pmid">3000248</pub-id></element-citation></ref><ref id="bib0275"><label>53.</label><element-citation publication-type="journal" id="sbref0275"><person-group person-group-type="author"><name><surname>McClung</surname><given-names>H.W.</given-names></name><name><surname>Knight</surname><given-names>V.</given-names></name><name><surname>Culbert</surname><given-names>B.E.</given-names></name></person-group><article-title>Ribavirin aerosol treatment of influenza B virus infection</article-title><source>JAMA</source><volume>249</volume><year>1983</year><fpage>2671</fpage><pub-id pub-id-type="pmid">6341642</pub-id></element-citation></ref><ref id="bib0280"><label>54.</label><element-citation publication-type="journal" id="sbref0280"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>J.B.</given-names></name><name><surname>King</surname><given-names>I.J.</given-names></name><name><surname>Webb</surname><given-names>P.A.</given-names></name></person-group><article-title>Lassa fever: Effective therapy with ribavirin</article-title><source>N Engl J Med</source><volume>314</volume><year>1986</year><fpage>20</fpage><pub-id pub-id-type="pmid">3940312</pub-id></element-citation></ref><ref id="bib0285"><label>55.</label><element-citation publication-type="journal" id="sbref0285"><person-group person-group-type="author"><name><surname>McLaren</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>M.S.</given-names></name><name><surname>Ghazzouli</surname><given-names>I.</given-names></name></person-group><article-title>Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir</article-title><source>Antimicrob Agents Chemother</source><volume>6</volume><year>1985</year><fpage>740</fpage></element-citation></ref><ref id="bib0290"><label>56.</label><element-citation publication-type="journal" id="sbref0290"><person-group person-group-type="author"><name><surname>Mertz</surname><given-names>G.J.</given-names></name><name><surname>Cathy</surname><given-names>W.</given-names></name><name><surname>Critchlou</surname><given-names>M.S.</given-names></name></person-group><article-title>Double-blind placebo-controlled trial of oral acyclovir in first episode genital herpes simplex virus infection</article-title><source>JAMA</source><volume>9</volume><year>1984</year><fpage>1147</fpage></element-citation></ref><ref id="bib0295"><label>57.</label><element-citation publication-type="journal" id="sbref0295"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>V.M.</given-names></name><name><surname>Dieisbach</surname><given-names>M.</given-names></name><name><surname>Bryson</surname><given-names>Y.J.</given-names></name></person-group><article-title>Double-blind controlled study of central nervous system side effects of amantadine hydrochloride, rimantadine hydrochloride, and chlorpheniramine</article-title><source>Antimicrob Agents Chemother</source><volume>21</volume><year>1982</year><fpage>1</fpage><pub-id pub-id-type="pmid">7044294</pub-id></element-citation></ref><ref id="bib0300"><label>58.</label><element-citation publication-type="journal" id="sbref0300"><person-group person-group-type="author"><name><surname>Mitguya</surname><given-names>H.</given-names></name><name><surname>Weinhold</surname><given-names>K.J.</given-names></name><name><surname>Furman</surname><given-names>P.A.</given-names></name></person-group><article-title>3&#x02019; azido-3&#x02019;-deoxythymidine: An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/LAV in vitro</article-title><source>Proc Natl Acad Sei USA</source><volume>82</volume><year>1985</year><fpage>1096</fpage></element-citation></ref><ref id="bib0305"><label>59.</label><element-citation publication-type="journal" id="sbref0305"><person-group person-group-type="author"><name><surname>Oxford</surname><given-names>J.S.</given-names></name><name><surname>Galbraith</surname><given-names>A.</given-names></name></person-group><article-title>Antiviral activity of amantadine: A review of laboratory and clinical data</article-title><source>Pharmacol Ther</source><volume>11</volume><year>1980</year><fpage>181</fpage><pub-id pub-id-type="pmid">6159656</pub-id></element-citation></ref><ref id="bib0310"><label>60.</label><element-citation publication-type="journal" id="sbref0310"><person-group person-group-type="author"><name><surname>Perslund</surname><given-names>N.A.</given-names></name><name><surname>Seyer-Hansen</surname><given-names>K.</given-names></name><name><surname>Ipsen</surname><given-names>J.</given-names></name></person-group><article-title>Acyclovir in herpes zoster</article-title><source>Lancet</source><volume>2</volume><year>1981</year><fpage>827</fpage><pub-id pub-id-type="pmid">6116951</pub-id></element-citation></ref><ref id="bib0315"><label>61.</label><element-citation publication-type="journal" id="sbref0315"><article-title>Prevention and control of influenza</article-title><source>MMWR</source><volume>35</volume><year>1986</year><fpage>317</fpage><pub-id pub-id-type="pmid">3010071</pub-id></element-citation></ref><ref id="bib0320"><label>62.</label><element-citation publication-type="journal" id="sbref0320"><person-group person-group-type="author"><name><surname>Reichman</surname><given-names>R.C.</given-names></name><name><surname>Badger</surname><given-names>G.J.</given-names></name><name><surname>Guiman</surname><given-names>M.E.</given-names></name></person-group><article-title>Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: A controlled trial</article-title><source>J Infect Dis</source><volume>2</volume><year>1983</year><fpage>336</fpage></element-citation></ref><ref id="bib0325"><label>63.</label><element-citation publication-type="journal" id="sbref0325"><person-group person-group-type="author"><name><surname>Reichman</surname><given-names>R.C.</given-names></name><name><surname>Badger</surname><given-names>C.J.</given-names></name><name><surname>Mertz</surname><given-names>G.J.</given-names></name></person-group><article-title>Treatment of recurrent genital herpes simplex infections with oral acyclovir</article-title><source>JAMA</source><volume>16</volume><year>1984</year><fpage>210</fpage></element-citation></ref><ref id="bib0330"><label>64.</label><element-citation publication-type="journal" id="sbref0330"><person-group person-group-type="author"><name><surname>Resnick</surname><given-names>L.</given-names></name><name><surname>Schleider-Kushner</surname><given-names>N.</given-names></name><name><surname>Horowitz</surname><given-names>S.N.</given-names></name></person-group><article-title>Remission of tumor-stage mycosis fungoides following intravenously administered acyclovir</article-title><source>JAMA</source><volume>12</volume><year>1984</year><fpage>1571</fpage></element-citation></ref><ref id="bib0335"><label>65.</label><element-citation publication-type="journal" id="sbref0335"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>W.</given-names></name><name><surname>Dormont</surname><given-names>D.</given-names></name><name><surname>Spire</surname><given-names>B.</given-names></name></person-group><article-title>Antimoniotungstate (HPA-23) treatment of three patients with AIDS and one with prodrome</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>450</fpage><pub-id pub-id-type="pmid">2857819</pub-id></element-citation></ref><ref id="bib0340"><label>66.</label><element-citation publication-type="journal" id="sbref0340"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>A.H.</given-names></name><name><surname>Julia</surname><given-names>A.</given-names></name><name><surname>Balakrishan</surname><given-names>C.</given-names></name></person-group><article-title>Toxicity of adenine arabinoside in humans</article-title><source>J Infect Dis</source><volume>133</volume><year>1976</year><fpage>A192</fpage><pub-id pub-id-type="pmid">180199</pub-id></element-citation></ref><ref id="bib0345"><label>67.</label><element-citation publication-type="journal" id="sbref0345"><person-group person-group-type="author"><name><surname>Sandstrom</surname><given-names>E.G.</given-names></name><name><surname>Bington</surname><given-names>R.E.</given-names></name><name><surname>Kaplan</surname><given-names>J.C.</given-names></name></person-group><article-title>Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>1480</fpage><pub-id pub-id-type="pmid">2409414</pub-id></element-citation></ref><ref id="bib0350"><label>68.</label><element-citation publication-type="journal" id="sbref0350"><person-group person-group-type="author"><name><surname>Scheman</surname><given-names>A.J.</given-names></name><name><surname>Steinberg</surname><given-names>I.</given-names></name><name><surname>Taddeini</surname><given-names>L.</given-names></name></person-group><article-title>Abatement of Sezary&#x02019;s syndrome lesions following treatment with acyclovir</article-title><source>Am J Med</source><volume>80</volume><year>1986</year><fpage>1199</fpage><pub-id pub-id-type="pmid">2942033</pub-id></element-citation></ref><ref id="bib0355"><label>69.</label><element-citation publication-type="journal" id="sbref0355"><person-group person-group-type="author"><name><surname>Scholley</surname><given-names>R.T.</given-names></name><name><surname>Carey</surname><given-names>R.W.</given-names></name><name><surname>Miller</surname><given-names>G.</given-names></name></person-group><article-title>Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis</article-title><source>Ann Intern Med</source><volume>104</volume><year>1986</year><fpage>636</fpage><pub-id pub-id-type="pmid">3008616</pub-id></element-citation></ref><ref id="bib0360"><label>70.</label><element-citation publication-type="journal" id="sbref0360"><person-group person-group-type="author"><name><surname>Scullard</surname><given-names>G.H.</given-names></name><name><surname>Andres</surname><given-names>L.L.</given-names></name><name><surname>Greenberg</surname><given-names>H.B.</given-names></name></person-group><article-title>Antiviral treatment of chronic hepatitis B virus infection. Improvement in liver disease with interferon and adenosine arabi- noside</article-title><source>Hepatology</source><volume>1</volume><year>1981</year><fpage>228</fpage><pub-id pub-id-type="pmid">6169615</pub-id></element-citation></ref><ref id="bib0365"><label>71.</label><element-citation publication-type="journal" id="sbref0365"><person-group person-group-type="author"><name><surname>Seale</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>C.J.</given-names></name><name><surname>Kathpalia</surname><given-names>S.</given-names></name></person-group><article-title>Prevention of herpesvirus infections in renal allograft recipients by low dose oral acyclovir</article-title><source>JAMA</source><volume>24</volume><year>1985</year><fpage>3435</fpage></element-citation></ref><ref id="bib0370"><label>72.</label><element-citation publication-type="journal" id="sbref0370"><person-group person-group-type="author"><name><surname>Shanley</surname><given-names>J.D.</given-names></name><name><surname>Morningstar</surname><given-names>J.</given-names></name><name><surname>Jordan</surname><given-names>C.M.</given-names></name></person-group><article-title>Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(l-2-dihydroxy-2-propoxy- methyl) guanine</article-title><source>Antimicrob Agents Chemother</source><volume>28</volume><year>1985</year><fpage>172</fpage><pub-id pub-id-type="pmid">3010835</pub-id></element-citation></ref><ref id="bib0375"><label>73.</label><element-citation publication-type="journal" id="sbref0375"><person-group person-group-type="author"><name><surname>Shepp</surname><given-names>D.H.</given-names></name><name><surname>Dandikir</surname><given-names>P.S.</given-names></name><name><surname>le Miranda</surname><given-names>P.</given-names></name></person-group><article-title>Activity of 9-[2-hydroxy-l-hydroxymethyl) ethoxymethyl] guanine in the treatment of cytomegalovirus pneumonia</article-title><source>Ann Intern Med</source><volume>103</volume><year>1985</year><fpage>368</fpage><pub-id pub-id-type="pmid">2992333</pub-id></element-citation></ref><ref id="bib0380"><label>74.</label><element-citation publication-type="journal" id="sbref0380"><person-group person-group-type="author"><name><surname>Shepp</surname><given-names>D.H.</given-names></name><name><surname>Newton</surname><given-names>B.A.</given-names></name><name><surname>Dandliker</surname><given-names>P.S.</given-names></name></person-group><article-title>Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients</article-title><source>Ann Intern Med</source><volume>102</volume><year>1985</year><fpage>783</fpage><pub-id pub-id-type="pmid">2986508</pub-id></element-citation></ref><ref id="bib0385"><label>75.</label><element-citation publication-type="journal" id="sbref0385"><person-group person-group-type="author"><name><surname>Straus</surname><given-names>S.E.</given-names></name><name><surname>Seidlin</surname><given-names>M.</given-names></name><name><surname>Takiff</surname><given-names>H.</given-names></name></person-group><article-title>Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients</article-title><source>Ann Intern Med</source><volume>100</volume><year>1984</year><fpage>522</fpage><pub-id pub-id-type="pmid">6703544</pub-id></element-citation></ref><ref id="bib0390"><label>76.</label><element-citation publication-type="journal" id="sbref0390"><person-group person-group-type="author"><name><surname>Straus</surname><given-names>S.E.</given-names></name><name><surname>Takiff</surname><given-names>H.E.</given-names></name><name><surname>Seidlin</surname><given-names>M.</given-names></name></person-group><article-title>Suppression of frequently recurring genital herpes</article-title><source>N Engl J Med</source><volume>24</volume><year>1984</year><fpage>1545</fpage></element-citation></ref><ref id="bib0395"><label>77.</label><element-citation publication-type="journal" id="sbref0395"><person-group person-group-type="author"><name><surname>Totzis</surname><given-names>P.</given-names></name><name><surname>Huany</surname><given-names>A.S.</given-names></name></person-group><article-title>Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infection cells</article-title><source>Antimicrob Agents Chemother</source><volume>29</volume><year>1986</year><fpage>1010</fpage><pub-id pub-id-type="pmid">3015012</pub-id></element-citation></ref><ref id="bib0400"><label>78.</label><element-citation publication-type="journal" id="sbref0400"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>R.B.</given-names></name><name><surname>Felton</surname><given-names>A.</given-names></name><name><surname>Kosak</surname><given-names>K.</given-names></name></person-group><article-title>Prevention of experimental Coronavirus colds with intranasal alpha 2b interferon</article-title><source>J Infect Dis</source><volume>3</volume><year>1986</year><fpage>443</fpage></element-citation></ref><ref id="bib0405"><label>79.</label><element-citation publication-type="journal" id="sbref0405"><person-group person-group-type="author"><name><surname>Tyrell</surname><given-names>D.A.J.</given-names></name></person-group><article-title>Interferons and their clinical value</article-title><source>Rev Infect Dis</source><volume>9</volume><year>1987</year><fpage>243</fpage><pub-id pub-id-type="pmid">2438740</pub-id></element-citation></ref><ref id="bib0410"><label>80.</label><element-citation publication-type="journal" id="sbref0410"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>M.</given-names></name><name><surname>Hirsch</surname><given-names>M.S.</given-names></name></person-group><article-title>Prospects for the prevention and therapy of infections with the human immunodeficiency virus</article-title><source>Rev Infect Dis</source><volume>8</volume><year>1986</year><fpage>991</fpage><pub-id pub-id-type="pmid">3541131</pub-id></element-citation></ref><ref id="bib0415"><label>81.</label><element-citation publication-type="journal" id="sbref0415"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>M.W.</given-names></name><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name><name><surname>Furman</surname><given-names>P.A.</given-names></name></person-group><article-title>Ribavirin antagonizes the effect of azidothymidine on HIV replication</article-title><source>Science</source><volume>235</volume><year>1987</year><fpage>1376</fpage><pub-id pub-id-type="pmid">2435003</pub-id></element-citation></ref><ref id="bib0420"><label>82.</label><element-citation publication-type="journal" id="sbref0420"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R.J.</given-names></name><name><surname>Alford</surname><given-names>C.A.</given-names></name><name><surname>Hirsch</surname><given-names>M.S.</given-names></name></person-group><article-title>Vidarabine versus acyclovir therapy in herpes simplex encephalitis</article-title><source>N Engl J Med</source><volume>314</volume><year>1986</year><fpage>144</fpage><pub-id pub-id-type="pmid">3001520</pub-id></element-citation></ref><ref id="bib0425"><label>83.</label><element-citation publication-type="journal" id="sbref0425"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R.J.</given-names></name><name><surname>Soong</surname><given-names>S.J.</given-names></name><name><surname>Dolin</surname><given-names>R.</given-names></name></person-group><article-title>Adenosine arabinoside therapy of biopsy proven HSV encephalitis. NI AID collaborative antiviral study</article-title><source>N Engl J Med</source><volume>297</volume><year>1977</year><fpage>289</fpage><pub-id pub-id-type="pmid">195208</pub-id></element-citation></ref><ref id="bib0430"><label>84.</label><element-citation publication-type="journal" id="sbref0430"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R.J.</given-names></name><name><surname>Soong</surname><given-names>S.J.</given-names></name><name><surname>Hirsch</surname><given-names>M.S.</given-names></name></person-group><article-title>HSV encephalitis: Vidarabine therapy and diagnostic problems</article-title><source>N Engl J Med</source><volume>304</volume><year>1981</year><fpage>313</fpage><pub-id pub-id-type="pmid">6255332</pub-id></element-citation></ref><ref id="bib0435"><label>85.</label><element-citation publication-type="journal" id="sbref0435"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R.J.</given-names></name><name><surname>Spruance</surname><given-names>S.</given-names></name><name><surname>Hayden</surname><given-names>P.G.</given-names></name></person-group><article-title>Vidarabine therapy for mucocutaneous HSV infections in immunocompromised hosts</article-title><source>J Infect Dis</source><volume>149</volume><year>1984</year><fpage>1</fpage><pub-id pub-id-type="pmid">6693782</pub-id></element-citation></ref><ref id="bib0440"><label>86.</label><element-citation publication-type="journal" id="sbref0440"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S.Z.</given-names></name><name><surname>Gilbert</surname><given-names>B.E.</given-names></name><name><surname>Quarles</surname><given-names>J.M.</given-names></name></person-group><article-title>Treatment of influenza A (HI Nl) virus infections with ribavirin aerosol</article-title><source>Antimicrob Agents Chemother</source><volume>26</volume><year>1984</year><fpage>200</fpage><pub-id pub-id-type="pmid">6486761</pub-id></element-citation></ref><ref id="bib0445"><label>87.</label><element-citation publication-type="journal" id="sbref0445"><person-group person-group-type="author"><name><surname>Yarchoan</surname><given-names>R.</given-names></name><name><surname>Weinhold</surname><given-names>K.J.</given-names></name><name><surname>Lyeely</surname><given-names>H.K.</given-names></name></person-group><article-title>Administration of 3&#x02019;-azido-3&#x02019;-deoxythymi-dine, an inhibitor of HTLV III/LAV replication to patients with AIDS or AIDS-related complex</article-title><source>Lancet</source><volume>1</volume><year>1986</year><fpage>575</fpage><pub-id pub-id-type="pmid">2869302</pub-id></element-citation></ref></ref-list></back></article>